Voloridge Investment Management’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-327,393	Closed	-$1.97M	–	1310
2025 Q4	$1.97M	Sell	327,393 -189,235	-37%	-$1.13M	0.01%	917
2025 Q3	$2.95M	Sell	516,628 -272,878	-35%	-$1.4M	0.01%	859
2025 Q2	$3.98M	Sell	789,506 -270,649	-26%	-$1.45M	0.01%	810
2025 Q1	$6.87M	Buy	1,060,155 +290,430	+38%	+$2.58M	0.03%	691
2024 Q4	$5.65M	Sell	769,725 -205,575	-21%	-$1.62M	0.02%	745
2024 Q3	$7.3M	Sell	975,300 -249,598	-20%	-$2.17M	0.03%	680
2024 Q2	$10.9M	Buy	1,224,898 +521,370	+74%	+$5M	0.04%	543
2024 Q1	$7.13M	Buy	703,528 +149,722	+27%	+$1.52M	0.03%	566
2023 Q4	$5.57M	Buy	553,806 +113,038	+26%	+$1.03M	0.02%	593
2023 Q3	$4.13M	Buy	+440,768	New	+$6.29M	0.02%	716
2022 Q1	–	Sell	-355,091	Closed	-$14.9M	–	1721
2021 Q4	$14.9M	Buy	355,091 +153,578	+76%	+$6.02M	0.08%	350
2021 Q3	$8.77M	Sell	201,513 -6,656	-3%	-$288K	0.06%	475
2021 Q2	$9.84M	Sell	208,169 -75,600	-27%	-$3.44M	0.07%	416
2021 Q1	$14.5M	Sell	283,769 -67,356	-19%	-$3.63M	0.11%	259
2020 Q4	$9.4M	Buy	+351,125	New	+$11.4M	0.08%	283